Immunocytochemical analysis of the MYC and NMYC expression of the well-established lung adenocarcinoma cell line LXF-289 revealed similar expressions for MYC and a slightly lower amount NMYC in comparison to BKZ populations (Figure 4M–N). The gene discussed is MYC; the disease is lung adenocarcinoma.